A surge in the number of people using slimming jabs to lose weight could lead to a rise in patients travelling abroad for tummy tucks or other surgery to remove excess skin, surgeons have said.
Drugs such as liraglutide and semaglutide, which could help people reduce their weight by more than 10%, have been approved for use on the NHS for certain groups of people with obesity, although supplies of the latter under the brand name Wegovy have yet to arrive in the UK.
